http://www.fpnotebook.com/
Schizophrenia
Aka: Schizophrenia
- See Also
- Psychosis
- Epidemiology
- Prevalence: 1% across all ethnicity, nationality
- Gender: Equal among men and women
- Men present in teen and early 20s
- Women present in their 20s and 30s
- Pathophysiology
- Polygenic condition (expression impacted by environ.)
- Protective factors in the family environment
- Uncommon criticism
- Straightforward communication
- Neurotransmitter Dopamine
- Increased Dopamine exacerbates positive symptoms
- Antipsychotics are primarily reduce Dopamine
- Risk Factors
- Family History (most significant risk)
- Monozygotic twin: 50% lifetime Incidence
- Dizygotic twin: 17% lifetime Incidence
- First degree relative: 6-17% lifetime Incidence
- Lewis (2000) Neuron 28:325-34
- Other risks (insufficient evidence)
- Socioeconomic factors
- Maternal infections
- Types
- See Psychosis Types
- Symptoms
- See Psychosis Symptoms
- Often preceded by prodromal phase
- Social withdrawal
- Loss of interest in school or work
- Hygiene and grooming deteriorate
- Angry outbursts
- Unusual behavior
- Signs
- See Psychosis Exam
- Labs
- See Psychosis Labs
- Differential Diagnosis
- See Psychosis Differential Diagnosis
- Diagnosis
- Schizophrenia Diagnosis
- Management
- See Neuroleptic Medications
- Pitfalls
- Atypical Antipsychotics offer no significant benefit
- Consider low dose first generation agents instead
- Patients stop their medications frequently
- Patients who stopped meds within 18 months: 74%
- Lieberman (2005) New Engl J Med 353:1209-23
- Delay in treatment significantly worsens prognosis
- Wyatt (1997) Psychol Med 27:261-8
- Monotherapy with a single Antipsychotic may be preferred
- However more than 50% of Schizophrenia patients may be on more than one Antipsychotic
- Consider adjunctive use of Antidepressants or mood stabilizers where appropriate
- Consider switching to a different Antipsychotic after an adequate duration and dose
- Consider Clozapine
- If a second Antipsychotic is required, consider an agent that balances the adverse effects of the first
- Barbui (2009) Schizophr Bull 35(2):458-68
- Prognosis
- High risk of Suicide (10% lifetime risk)
- References
- (2000) DSM IV, APA, p. 297-343
- Freedman (2003) N Engl J Med 349:1738-49
- Lewis (2000) Neuron 28:325-34
- Schultz (2007) Am Fam Physician 75:1821-9